IBDEI0DM ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6551,2)
 ;;=DM Type II with LE Ulcer^267846^707.10
 ;;^UTILITY(U,$J,358.3,6552,0)
 ;;=250.00^^55^568^5
 ;;^UTILITY(U,$J,358.3,6552,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6552,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,6552,1,5,0)
 ;;=5^DM Type II Dm W/O Complications
 ;;^UTILITY(U,$J,358.3,6552,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,6553,0)
 ;;=250.40^^55^568^6
 ;;^UTILITY(U,$J,358.3,6553,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6553,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,6553,1,5,0)
 ;;=5^DM Type II Dm with Nephropathy
 ;;^UTILITY(U,$J,358.3,6553,2)
 ;;=^267837^583.81
 ;;^UTILITY(U,$J,358.3,6554,0)
 ;;=250.50^^55^568^9
 ;;^UTILITY(U,$J,358.3,6554,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6554,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,6554,1,5,0)
 ;;=5^DM Type II w/ PDR
 ;;^UTILITY(U,$J,358.3,6554,2)
 ;;=DM Type II w/ PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,6555,0)
 ;;=250.60^^55^568^7
 ;;^UTILITY(U,$J,358.3,6555,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6555,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,6555,1,5,0)
 ;;=5^DM Type II Dm with Neuropathy
 ;;^UTILITY(U,$J,358.3,6555,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,6556,0)
 ;;=250.70^^55^568^8
 ;;^UTILITY(U,$J,358.3,6556,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6556,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,6556,1,5,0)
 ;;=5^DM Type II Dm with Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,6556,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,6557,0)
 ;;=250.01^^55^568^4
 ;;^UTILITY(U,$J,358.3,6557,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6557,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,6557,1,5,0)
 ;;=5^DM Type I DM W/O Complications
 ;;^UTILITY(U,$J,358.3,6557,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,6558,0)
 ;;=272.0^^55^568^22
 ;;^UTILITY(U,$J,358.3,6558,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6558,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,6558,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,6558,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,6559,0)
 ;;=272.1^^55^568^28
 ;;^UTILITY(U,$J,358.3,6559,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6559,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,6559,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,6559,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,6560,0)
 ;;=272.2^^55^568^24
 ;;^UTILITY(U,$J,358.3,6560,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6560,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,6560,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,6560,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,6561,0)
 ;;=275.42^^55^568^21
 ;;^UTILITY(U,$J,358.3,6561,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6561,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,6561,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,6561,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,6562,0)
 ;;=275.41^^55^568^29
 ;;^UTILITY(U,$J,358.3,6562,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6562,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,6562,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,6562,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,6563,0)
 ;;=276.7^^55^568^23
 ;;^UTILITY(U,$J,358.3,6563,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6563,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,6563,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,6563,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,6564,0)
 ;;=275.2^^55^568^19
 ;;^UTILITY(U,$J,358.3,6564,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6564,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,6564,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,6564,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,6565,0)
 ;;=276.0^^55^568^25
